Back to search

Switzerland· 68221001

MenQuadfi, solution injectable

A meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert product containing polysaccharida neisseriae meningitidis a, polysaccharida neisseriae meningitidis c, polysaccharida neisseriae meningitidis y, toxoidum tetani, registered in Switzerland by Sanofi-Aventis (Suisse) SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC J07AH08

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMenQuadfi, solution injectableATCJ07AH08REGISTER NO.68221001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert is registered in 11 of 19 countries.

Countries holding a registration under ATC J07AH08 (meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert · ATC J07AH08

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
polysaccharida neisseriae meningitidis A, polysaccharida neisseriae meningitidis C, polysaccharida neisseriae meningitidis Y, toxoidum tetani
Manufacturer
Sanofi-Aventis (Suisse) SA
Country
Switzerland (CH)
ATC code
J07AH08
ATC class
Meningokokken A, C, Y, W-135, tetravalent, gereinigtes Polysaccharid-Antigen, konjugiert
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680682210015
    Durchstf 0.5 ml
    CHF 61.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/037bdad9-6f5f-4d51-96b8-7da07bebf188
GET /v1/drugs/037bdad9-6f5f-4d51-96b8-7da07bebf188?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "polysaccharida neisseriae meningitidis a 10 mcg + polysaccharida neisseriae meningitidis c 10 mcg + polysaccharida neisseriae meningitidis w135 10 mcg + polysaccharida neisseriae meningitidis y 10 mcg + vaccinum meningitidis polysaccharid. tetravalens a, c, w135, y conjugatum t",
  "valid_from": "2023-06-01",
  "limitations": "[{\"description\":\"Kostenübernahme bei Kindern ab 1 Jahr.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-01-01\"}]",
  "galenic_form": "Inj Lös",
  "therapeutic_area": null,
  "sl_inclusion_date": "2023-06-01",
  "self_retention_pct": 10
}

See everything about meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.